Together, these data revealed that MPNST cell survival and tumor growth are driven by RABL6A, but how it cooperates with Ink4a and Arf loss to promote MPNST progression is not known. This evidence concerns the gene CDKN2A and malignant peripheral nerve sheath tumor.